In invasive carcinomas of the breast (BRCA), thyroid carcinoma (THCA), uterine corpus endometrial carcinoma (UCEC) and uterine carcinosarcoma (UCS) HIF2A expression is 3- to ninefold more expressed in normal than in cancer samples. This evidence concerns the gene EPAS1 and uterine carcinosarcoma.